SLC31A1 and ovarian neoplasm: The increase in cellular accumulation of platinum and the level of Pt − DNA binding associated with combination of BORT with CB and OX in ovarian tumour models indicate that BORT may serve to protect CTR1 from CS-induced proteasomal degradation.